Announcements

The COVID-19 vaccine, BCVax, has been granted by TFDA to proceed to Phase I clinical trial

1.Date of occurrence of the event:2023/06/02 2.New drug name or code:COVID-19 vaccine, BCVax 3.Indication: COVID-19 vaccine, BCVax, is composed of the Delta spike protein with nanoparticle saponins as adjuvant that …

Announcement of change Spokesperson

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development …

Announcement of change of CEO

1.Date of the board of directors resolution or date of occurrence of the change: 2023/06/02 2.Position (Please enter chairperson or president/general manager): CEO 3.Name of the previous position holder: Yun …

Announcement on behalf of Obigen that the BOD resolved to issue 2023 employee stock options and the subscription rules.

1.Date of the board of directors resolution:2023/05/26 2.Issue period: Issued within two years since the date of approval of Board of Directors; issued at once or in tranches depending on …

Announcement on behalf of Obigen to change its financial and accounting officer

1.Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.), financial officer, accounting officer, corporate governance officer, chief information security officer, research and development …

The Company’s BOD resolved to amend the plan to disperse shareholding of Obigen (New Shareholding Dispersal Method)

1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: N/A 5.Cause of occurrence: To …

The Company’s BOD resolved to amend the plan to disperse shareholding of AP Biosciences (New Shareholding Dispersal Method)

1.Date of occurrence of the event:2023/05/08 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios: N/A 5.Cause of occurrence: To …

The Company’s Board of Directors resolved to issue 2023 employee stock options and the subscription rules.

1.Date of the board of directors resolution:2023/05/08 2.Issue period Pursuant to the “Regulations Governing the Offering and Issuance of Securities by Securities Issuers”, issued within one year since the date …

The Company’s Board of Directors resolved to convene the 2023 Annual General Shareholders’ Meeting (New Approval)

1.Date of the board of directors resolution:2023/05/08 2.General shareholders’ meeting date:2023/06/27 3.General shareholders’ meeting location: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Taipei City) …

Announcement of the Consolidated Financial Statements for the first quarter of 2023 were approved by the Board of Directors.

1.Date of the board of directors submitted or approved:2023/05/08 2.Date of the audit committee approved:2023/05/08 3.Start and end dates of financial reports or unaudited financial information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):2023/01/01~2023/03/31 …